Ella R. Thompson - Concepedia

Author

Ella R. Thompson

Also Known As

David Y. H. Choong, E Thompson, E. R. Thompson, E. Thompson, Ella R Thompson, Ella R. Thompson, Ella Thompson, Emily R. Thompson, Ian Campbell, LifePool Investigators

154

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne The Royal Melbourne Hospital Walter and Eliza Hall Institute of Medical Research Monash University

About

Ella R. Thompson is an author at Peter MacCallum Cancer Centre specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.3K
2	Engineering	3	3	267
3	Health Sciences	3	3	194
4	Public Health	3	3	143
5	Biostatistics	2	2	55

Ella R. Thompson

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia Piers Blombery, Mary Ann Anderson, Jianan Gong, Cancer Discovery	2018	412
CONTRA: copy number analysis for targeted resequencing Jason Li, Richard Lupat, Kaushalya Amarasinghe, Bioinformatics	2012	383
SNORD-host RNA <i>Zfas1</i> is a regulator of mammary development and a potential marker for breast cancer Marjan Askarian-Amiri, Joanna Crawford, Juliet D. French, RNA	2011	338
No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas Wen Qiu, Min Hu, Anita Sridhar, Nature Genetics Human BreastBreast OncologySomatic VariantSomatic Cell GeneticsOvarian Carcinomas	2008	279
Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles Ella R. Thompson, Maria Doyle, Georgina L. Ryland, PLoS Genetics Candidate Gene ApproachesGenome InstabilityEngineeringSomatic VariantGenetic Disorder	2012	211
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study Amit Khot, Natalie Brajanovski, Donald P. Cameron, Cancer Discovery	2019	197
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care Ella R. Thompson, Simone M. Rowley, Na Li, Journal of Clinical Oncology	2016	183
High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications Kylie L. Gorringe, Sharoni Jacobs, Ella R. Thompson, Clinical Cancer Research	2007	171
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1 T.-C. Teh, N-Y Nguyen, Donia M. Moujalled, Leukemia Hematological MalignancyTumor BiologyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood Disorder	2017	149
No evidence that protein truncating variants in <i>BRIP1</i> are associated with breast cancer risk: implications for gene panel testing Douglas F. Easton, Fabienne Lesueur, Brennan Decker, Journal of Medical Genetics	2016	102

Page 1